These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38907189)

  • 1. Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels.
    Pardo J; Capdevila-Lacasa C; Segura B; Pané A; Montserrat C; de Talló Forga-Visa M; Moreno PJ; Garrabou G; Grau-Junyent JM; Junqué C;
    J Neurodev Disord; 2024 Jun; 16(1):33. PubMed ID: 38907189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R; Osterloh J; Onon S; Fromm J; Rutsch F; Weglage J
    Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study.
    Nardecchia F; Manti F; Chiarotti F; Carducci C; Carducci C; Leuzzi V
    Mol Genet Metab; 2015; 115(2-3):84-90. PubMed ID: 25952249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.
    Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D
    Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow and white matter alterations in adults with phenylketonuria.
    Steiner L; Muri R; Wijesinghe D; Jann K; Maissen-Abgottspon S; Radojewski P; Pospieszny K; Kreis R; Kiefer C; Hochuli M; Trepp R; Everts R
    Neuroimage Clin; 2024; 41():103550. PubMed ID: 38091797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria.
    Palaiodimou L; Zompola C; Lachanis S; Mylona V; Theodorou A; Papagiannopoulou G; Kotsali-Peteinelli V; Foska A; Kasti A; Skouma A; Tsivgoulis G
    Neurologist; 2020 Dec; 26(1):20-21. PubMed ID: 33394907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.
    Leuzzi V; Tosetti M; Montanaro D; Carducci C; Artiola C; Carducci C; Antonozzi I; Burroni M; Carnevale F; Chiarotti F; Popolizio T; Giannatempo GM; D'Alesio V; Scarabino T
    J Inherit Metab Dis; 2007 Apr; 30(2):209-16. PubMed ID: 17245558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R; Moats R; Guttler F; Guldberg P; Nelson M
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
    Brumm VL; Azen C; Moats RA; Stern AM; Broomand C; Nelson MD; Koch R
    J Inherit Metab Dis; 2004; 27(5):549-66. PubMed ID: 15669671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.
    Sundermann B; Pfleiderer B; Möller HE; Schwindt W; Weglage J; Lepsien J; Feldmann R
    J Inherit Metab Dis; 2011 Jun; 34(3):711-21. PubMed ID: 21491106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.